Table 3 Costs due to PCa by type of resource, Stockholm Region and Sweden, 2016 (€)
From: The economic burden of prostate cancer – a Swedish prevalence-based register study
Type of resource | Stockholm Region | Sweden | ||
|---|---|---|---|---|
Costs (€) | Costs (%) | Costs (€) | Costs (%) | |
Healthcare related costs | 39,765,502 | 61.6% | 162,462,861 | 57.9% |
Inpatient care | 10,457,640 | 16.2% | 41,041,967 | 14.6% |
Outpatient care | 10,025,188 | 15.5% | 40,450,037 | 14.4% |
Primary care | 4,810,643 | 7.5% | 17,782,058 | 6.3% |
Palliative care | 3,748,553 | 5.8% | 17,914,185 | 6.4% |
Pharmaceuticals | 10,723,478 | 16.6% | 45,274,615 | 16.1% |
Informal care | 18,120,816 | 28.1% | 89,142,341 | 31.7% |
Productivity losses | 6,626,929 | 10.3% | 29,176,618 | 10.4% |
Morbidity – Sick leave | 2,783,210 | 4.3% | 8,534,334 | 3.0% |
Morbidity – Early retirement | 256,420 | 0.4% | 806,630 | 0.3% |
Pre-mature mortality | 3,587,299 | 5.6% | 19,835,654 | 7.1% |
Total | 64,513,247 | 100% | 280,781,820 | 100.0% |